Molecule intelOpportunity: Moderate0Crowded market

Iron Salts

232 brands · 161 companies · product forms

1 DRAP alert

Opportunity snapshot

Launch attractiveness
37
Market saturation
100
Price room
100
Regulatory risk
50
232
brands
161
companies
Rs 151.38
median price
49
price points
148.71x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 2%

Price room

Across observed sources and strengths
CheapestRs 45.3
MedianRs 151.38
Most expensiveRs 6,736.39
Spread148.71×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 148.71x across 49 trusted points (Rs 45.3-6736.39). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Iron Salts — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2023-01-28
Recall Alert: Drug Product; Awahaem Tablets (Batch # 2781 by M/s. Usawa Pharmaceuticals, R

Why this score

Launch attractiveness

40% supply-gap(20) + 25% price-variation(100) + 20% low-competition(0) + 15% supply-disruption(40), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

161 canonical companies and 232 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 148.71x across 49 trusted points (Rs 45.3-6736.39). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2023-01-28 incl. recall/safety.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.